Roche signs Dx development deal with Pacific Biosciences

09/26/2013 | American City Business Journals

Pacific Biosciences of California has struck a deal to develop and sell sequencing tools and consumables exclusively to Roche Diagnostics. Pacific Biosciences will receive $35 million in cash and potentially $40 million more from the deal, which also gives Roche exclusive rights to use the technologies for nucleic acid sequencing for in vitro diagnostics for humans.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC